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Abstract 
Background: This study aimed to identify the most prevalent unmet needs of haematological cancer survivors.
Methods: Haematological cancer survivors aged 18–80 years at time of recruitment were selected from four Austral‑
ian state cancer registries. Survivors completed the Survivor Unmet Needs Survey. The most frequently reported 
“high/very high” unmet needs items were identified, as well as characteristics associated with the three most preva‑
lent “high/very high” unmet needs reported by haematological cancer survivors.
Results: A total of 715 eligible survivors returned a completed survey. “Dealing with feeling tired” (17%), was the 
most frequently endorsed “high/very high” unmet need. Seven out of the ten most frequently endorsed unmet needs 
related to emotional health. Higher levels of psychological distress (e.g., anxiety, depression and stress) and indicators 
of financial burden as a result of cancer (e.g., having used up savings and trouble meeting day‑to‑day expenses due 
to cancer) were consistently identified as characteristics associated with the three most prevalent “high/very high” 
unmet needs.
Conclusions: A minority of haematological cancer survivors endorsed a “high/very high” unmet need on individual 
items. Additional emotional support may be needed by a minority of survivors. Survivors reporting high levels of 
psychological distress or those who experience increased financial burden as a result of their cancer diagnosis may be 
at risk of experiencing the most prevalent “high/very high” unmet needs identified by this study.
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Background
Haematological cancers are a diverse group of can-
cers. Some are acute and fast growing, while others are 
chronic in nature [1]. Treatment types are variable, rang-
ing from intense, inpatient treatments, such as stem cell 
or bone marrow transplant, to regimes of “watchful-wait-
ing” [1]. Survival rates for some haematological cancers 
have improved in a number of countries [2–4]. As people 
are living longer after a cancer diagnosis it is vital that 
cancer care reduces the impact of cancer experienced by 
survivors [5, 6]. A cancer survivor has been defined as a 
person diagnosed with cancer from the time of diagnosis 
until death [7].
Supportive care is an integral component of health-
care [8, 9] and involves the provision of necessary ser-
vices to meet patients’ needs [8]. This includes physical, 
emotional, social, psychological, informational, spiritual 
and practical needs [8]. Designing programs and services 
that best address the needs of cancer survivors has been 
identified as a priority [6]. Information from cancer sur-
vivors themselves is crucial for developing and delivering 
appropriate supportive care services to cancer survivors.
Few studies have explored the supportive care needs of 
haematological cancer survivors [10]. Such research has 
been limited by small sample sizes, a lack of population-
based samples and a failure to use comprehensive and 
standardized needs assessment tools [10]. The authors 
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recently assessed the top unmet needs items of Austral-
ian and Canadian population-based samples of haema-
tological cancer survivors using a comprehensive needs 
assessment tool [11]. However, these findings focused on 
survivors from one Australian state only [11]. To increase 
the generalizability of the findings a more comprehensive 
assessment of haematological cancer survivors’ unmet 
needs, to include several Australian states, is needed.
Understanding what areas haematological cancer sur-
vivors require help with will facilitate improvements to 
the quality and appropriateness of supportive care pro-
vided to this population. Furthermore, identifying the 
sub-groups of survivors who may be at risk of experienc-
ing a higher level of unmet need will help to deliver and 
target timely supportive care to those who need it most. 
Extending on our previous research, this brief report 
aimed to identify the ten most frequently endorsed 
“high/very high” unmet needs among a large sample of 
haematological cancer survivors, as well as the character-
istics associated with the three most prevalent “high/very 




Adult haematological cancer survivors were recruited 
from four Australian state-based cancer registries and 
asked to complete a self-report pen-and-paper survey.
Participants
Eligible survivors were aged 18–80  years at time of 
recruitment and diagnosed with a haematological cancer.
Procedure
The standard recruitment procedures of each cancer 
registry were used. Registry A used a direct patient 
contact model of recruitment, whereby all eligible sur-
vivors were identified by the registry and mailed a 
questionnaire package. Non-responders were mailed a 
reminder questionnaire package approximately 4 weeks 
later (methods reported elsewhere) [12]. The three 
remaining registries (B, C & D) employed a rolling 
recruitment method, where survivors were identified 
and approached on an ongoing basis between Septem-
ber 2011 and July 2012. Passive clinician consent was 
sought from the treating clinicians of all eligible survi-
vors. This model of recruitment involved the registries 
notifying each eligible survivor’s treating clinician of 
intent to contact the survivor regarding the study. If cli-
nicians did not object to the registry contacting their 
patient in a specified period of time, the registry con-
tacted the survivor, informed them of the study [13], 
and requested their consent to have their contact details 
released to the researchers. Survivors who consented to 
having their contact details released from the registry 
to the researchers were sent a questionnaire package by 
the researchers. Non-responders were mailed a second 
questionnaire package approximately 4 weeks later and 
contacted by telephone after a further 4 weeks. Return 
of a completed survey was taken as informed consent to 
participate. Ethics approval was obtained from the Uni-
versity of Newcastle Human Research Ethics Commit-
tee and the relevant ethics committees associated with 
each cancer registry.
Measures
The Survivors Unmet Needs Survey (SUNS) contains 
a total of 89 items and assesses unmet needs across five 
domains: Financial Concerns (11 items), Emotional 
Health (33 items), Access and Continuity of Care (22 
items), Information (8 items) and Relationships (15 
items) [14]. Each item is scored from 0 (‘no unmet need’) 
to 4 (‘very high unmet need’) [14]. The SUNS has been 
found to be a relevant instrument for use with haemato-
logical cancer survivors with good psychometric proper-
ties in this population [15].
Age, sex, cancer type, postcode, diagnosis date and 
other disease and demographic information were 
obtained directly from the cancer registries for those 
survivors who provided consent. Other socio-demo-
graphic information was obtained from the self-report 
survey. De-identified non-participant data relating to 
age at diagnosis, cancer type, rural/urban location at 
diagnosis and sex were also obtained from the cancer 
registries.
Statistical analysis
Chi-squared analyses were used to compare character-
istics of participants and non-participants. For each of 
the 89 items of the SUNS ‘high’ and ‘very high’ responses 
were combined. The number and percentage of survi-
vors reporting a “high/very high” unmet need for each of 
the 89 items was calculated with 95% confidence inter-
vals and ranked from highest to lowest [11, 14]. The ten 
most highly endorsed “high/very high” unmet needs were 
identified. Separate logistic regression analyses were used 
to identify demographic, disease, treatment, social and 
psychological characteristics associated with each of the 
three most prevalent “high/very high” unmet needs items 
reported by haematological cancer survivors. Variables 
with a p-value of 0.2 or less on χ2 analyses were included 
in the logistic regression analysis and a backwards step-
wise method was used to remove variables with a p-value 
of 0.1 or more on the likelihood ratio test. The Hosmer–
Lemeshow goodness of fit test was used to assess the fit 
of each model.
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Results
Participants
Of the 1957 eligible survivors approached by the regis-
tries 715 (37%) returned completed surveys. A flowchart 
detailing the recruitment of the 715 haematological can-
cer survivors from each of the four cancer registries for 
the larger study is published elsewhere [16]. The sociode-
mographic and disease characteristics of participants, 
including: time since diagnosis, sex, cancer type and age-
group at diagnosis, are shown in Table 1. Age at diagnosis 
and cancer type were statistically significantly different 
between participants and non-participants.
Top unmet needs
The ten most frequently endorsed “high/very high” 
unmet needs items are presented in Table 2. Seven of the 
top ten most frequently endorsed “high/very high” unmet 
needs were from the Emotional Health domain, two from 
the Relationships domain and one from the Financial 
Concerns domain.
As shown in Table  2 “Dealing with feeling tired” was 
the most frequently reported unmet need. Survivors 
reporting that they had used up their savings as a result 
of cancer and treatment reported higher odds [OR 3.0; 
95% CI 1.73, 5.14; likelihood ratio (LR) χ2 = 15.1, df = 1, 
p  <  0.001] of experiencing a “high/very high” level of 
unmet need in regards to dealing with feeling tired com-
pared to those survivors who did not report such finan-
cial burden. Survivors who reported above normal levels 
of depression (OR 3.9; 95% CI 2.16, 7.17; LR χ2 = 19.79, 
df = 1, p < 0.001), or anxiety (OR 2.7; 95% CI 1.50, 4.99; 
LR χ2 = 10.53, df = 1, p = 0.001), or stress (OR 3.6; 95% 
CI 1.95, 6.78; LR χ2 = 16.48, df = 1, p < 0.001) had sig-
nificantly higher odds of experiencing a “high/very high” 
level of unmet need in relation to this item.
“Coping with having a bad memory or lack of focus” 
was the second most prevalent “high/very high” unmet 
need (Table  2). Survivors aged 50–59 years at diagnosis 
reported higher odds of experiencing a “high/very high” 
unmet need regarding this item (OR 4.0; 95% CI 1.40, 
11.60; LR χ2 = 14.63, df = 4, p = 0.01) than those aged 
70 years and over at diagnosis. Those with a high school 
or lower education reported significantly higher odds 
(OR 3.4; 95% CI 1.47, 7.97; LR χ2 = 8.87, df = 2, p = 0.01) 
than survivors with a university degree or higher qualifi-
cation. Survivors who reported using up their savings as a 
result of cancer and treatment had higher odds of report-
ing a high level of need for this item compared to those 
survivors who did not (OR 2.3; 95% CI 1.07, 5.02; LR 
χ2 =  4.45, df =  1, p =  0.04). Survivors reporting above 
normal levels of depression (OR 3.7; 95% CI 1.87, 7.40; 
LR χ2 = 13.64, df = 1, p < 0.001) or stress (OR 10.1; 95% 
CI 5.11, 20.0; LR χ2 = 47.56, df = 1, p < 0.001) had signif-
icantly higher odds of experiencing a high level of unmet 
Table 1 Participant demographic characteristics
a Totals may not add to equal the final sample size due to missing values.
Characteristica N (%) (total sample = 715)
Median time since diagnosis 35 months (SD = 18.5).
Sex
 Male 390 (59%)
 Female 275 (41%)
Cancer type
 Non‑Hodgkin’s lymphoma 387 (58%)
 Leukaemia 130 (20%)
 Myeloma 107 (16%)
 Hodgkin’s lymphoma 41 (6.2%)
Age group at diagnosis (years)
 15–39 53 (8.0%)
 40–49 71 (11%)
 50–59 174 (26%)
 60–69 235 (35%)
 70–80 132 (20%)
Table 2 Top ten ‘high/very high’ unmet needs reported by haematological cancer survivors
NB: observations with missing data ranged from 2.1 to 5.3% across the 89 unmet needs items.
Rank Unmet need N (%) (n = 715) SUNS domain
1 Dealing with feeling tired 116 (17%) Emotional Health
2 Coping with having a bad memory or lack of focus 99 (14%) Emotional Health
3 Dealing with feeling worried (anxious) 94 (13%) Emotional Health
4 Dealing with changes in my physical ability 93 (13%) Emotional Health
4 Finding someone to talk to who understands and has been through a similar experience 93 (13%) Relationships
6 Dealing with people who expect me to be “back to normal” 87 (12%) Relationships
7 Dealing with feeling stressed 86 (12%) Emotional Health
7 Dealing with not feeling able to set future goals or make long‑term plans 86 (12%) Emotional Health
9 Finding car parking that I can afford at the hospital or clinic 83 (12%) Financial Concerns
9 Dealing with being told I had cancer 83 (12%) Emotional Health
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need in relation to coping with having a bad memory 
or lack of focus compared to survivors with normal lev-
els of depression or normal levels of stress, respectively. 
Although not statistically significant at the 5% level, sur-
vivors in a partnered relationship had marginally higher 
odds (OR 2.2; 95% CI 0.99, 4.97; LR χ2 =  4.03, df =  1, 
p = 0.04) of reporting a “high/very high” unmet need for 
this item than those survivors who were single.
The third most highly endorsed unmet need was “deal-
ing with feeling worried (anxious)” (Table  2). Survivors 
reporting having trouble meeting day to day expenses 
due to their cancer and treatment had higher odds (OR 
3.1; 95% CI 1.47, 6.47; LR χ2 = 8.67, df = 1, p = 0.003) 
of reporting a “high/very high” unmet need in relation to 
this item than those who did not. Survivors who reported 
higher than normal levels of depression (OR 4.3; 95% CI 
2.16, 8.62; LR χ2 = 17.04, df = 1, p < 0.001) or stress (OR 
8.7; 95% CI 4.48, 16.90; LR χ2 = 43.63, df = 1, p < 0.001) 
had higher odds of reporting a “high/very high” level of 
unmet need on this item compared to their counterparts.
Discussion
Relatively few haematological cancer survivors endorsed 
a high or very high unmet need on individual items from 
the SUNS. This finding is consistent with our investiga-
tion of Australian and Canadian haematological can-
cer survivors [11] as well as prior research assessing the 
unmet needs of haematological [17] and heterogeneous 
samples [14, 18] of cancer survivors. This data suggests 
that the care provided to haematological cancer survivors 
may be adequate in meeting the majority of their needs.
Health care providers should aim to provide haemato-
logical cancer survivors with supportive care that specifi-
cally addresses their unmet needs. In this study “dealing 
with feeling tired” was the most frequently endorsed 
“high/very high” unmet need. Previous research has 
identified cancer-related fatigue as a prevalent symptom 
experienced by haematological cancer survivors [19–21]. 
In line with clinical practice guidelines health care pro-
viders should assess all haematological cancer survivors 
for cancer-related fatigue and provide appropriate sup-
port, as recommended by clinical practice guidelines, to 
those experiencing such symptoms [22].
The majority of the top ten most frequently endorsed 
“high/very high” unmet needs were from the emotional 
health domain. This finding is consistent with previ-
ous research assessing the unmet needs of cancer sur-
vivors, with most of the top unmet needs identified in 
these studies belonging to emotional or psychological 
domains [11, 18]. Methodologically rigorous interven-
tion trials aimed at identifying strategies that successfully 
reduce the most prevalent “high/very high” unmet needs 
of haematological cancer survivors may be warranted. 
However, a recent review found that few interventions 
have been effective in reducing the unmet needs of can-
cer patients [23]; although most of the previous research 
has not been conducted with haematological cancer sur-
vivors, further highlighting the need for research in this 
area.
This study found that elevated levels of psychologi-
cal symptoms (either depression, anxiety or stress) and 
increased financial burden as a result of having cancer, 
(e.g. having used up their savings and trouble meet-
ing day-to-day expenses), were characteristics consist-
ently associated with haematological cancer survivors’ 
three most frequently reported “high/very high” unmet 
needs. This is similar to previous research conducted 
by the authors, which identified elevated psychological 
symptoms and increased financial burden as a result of 
cancer to be associated with haematological cancer sur-
vivors reporting a “high/very high” level of unmet need 
on seven or more items of the SUNS [16]. These results 
suggest that such sub-groups of haematological cancer 
survivors maybe at increased risk of experiencing “high/
very high” unmet needs and additional support should be 
provided to these specific sub-groups. In addition, sup-
port targeted towards the most prevalent unmet needs 
identified by haematological cancer survivors may be 
most beneficial in alleviating unmet needs particularly 
among the most vulnerable sub-groups. Health care pro-
viders should consider using a psychometrically valid and 
reliable, as well as relevant measure, such as the SUNS, to 
assist them in identifying the specific areas haematologi-
cal cancer survivors wish to receive additional support 
with. Such information should be used to direct and pro-
vide appropriate support.
Several limitations of this study should be acknowl-
edged. The current sample was not representative of the 
entire population of haematological cancer survivors, 
with non-participants and participants differing with 
regard to age at diagnosis and cancer type. It is impor-
tant to be cautious when generalising from these results 
to the wider population of haematological cancer sur-
vivors. While the response rate of 37% was low, this is 
comparable to several other psychosocial surveys utilis-
ing population-based cancer registries [14, 18]. In addi-
tion, extensive efforts were made to increase the response 
rates in the current study, including the undertaking of 
a randomised controlled trial to increase response rates 
from one of the state cancer registries [12] and conduct-
ing follow-up reminders with non-responders.
Despite these limitations this study provides important 
and much needed information on the supportive care 
needs of haematological cancer survivors. With a sam-
ple of over 700 survivors this is the largest study we are 
aware of that assesses the specific supportive care unmet 
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needs of haematological cancer survivors [10]. This study 
also includes a large heterogonous, population-based 
sample of adult haematological cancer survivors, provid-
ing data from most sub-groups of haematological cancer 
survivors. Finally, the use of a comprehensive and rel-
evant needs assessment tool [15] helps to ensure that the 
data provide an accurate reflection of the most prevalent 
unmet needs of haematological cancer survivors. Such 
information should be used by health care providers and 
researchers to improve the supportive care provided to 
haematological cancer survivors.
Conclusion
Only a minority of haematological cancer survivors 
endorsed a “high/very high” unmet need on individual 
items. This finding may indicate that current support-
ive care is sufficient for meeting the majority of needs 
for most haematological cancer survivors. However, 
additional support, particularly in the area of emotional 
support may be needed by a minority of survivors. In par-
ticular, haematological cancer survivors who report high 
levels of psychological distress or experience increased 
financial burden as a result of their cancer diagnosis may 
be sub-groups of survivors at risk of experiencing an 
increased number of “high/very high” unmet needs items.
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